Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not).
about
ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases.Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study.Immune-related endocrine disorders in novel Immune checkpoint inhibition therapy.
P2860
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not).
@en
Ipilimumab-induced endocrinopathies: when to start corticosteroids
@nl
type
label
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not).
@en
Ipilimumab-induced endocrinopathies: when to start corticosteroids
@nl
prefLabel
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not).
@en
Ipilimumab-induced endocrinopathies: when to start corticosteroids
@nl
P2093
P2860
P1476
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not)
@en
P2093
Francesco Torino
Liana De Vecchis
Roberto Salvatori
Salvatore Maria Corsello
P2860
P2888
P304
P356
10.1007/S00280-013-2213-Y
P577
2013-06-19T00:00:00Z
P6179
1021002644